| Your Current Location : Fund Card : Portfolio Classification |
 |
|
|
| |
| Nippon India Nifty Pharma ETF |
| [Equity: Index] |
|
| |
|
|
| Instruments Breakdown |
| Instruments |
Composition |
| Current Asset |
0.03 |
| Equity |
99.90 |
| Trep |
0.07 |
|
| |
| Concentration Analysis |
| Top 5 Holdings |
54.56% |
| Top 10 Holdings |
77.98% |
| Top 25 Holdings |
100.00% |
|
|
|
| |
| Sector Analysis |
| Sector/Ratings |
Net Asset(%) |
| Pharma & Biotech |
99.9 |
| Cash |
0.1 |
|
|
|
|
|
| Portfolio Metrics |
|
| PB Ratio |
4.82 |
| PE Ratio |
38.04 |
|
| |
| Top 25 Holdings |
|
|
| Holdings |
Net Asset(%) |
| Sun Pharmaceutical Industries Limited |
21.30 |
| DIVI LABORATORIES LTD |
9.03 |
| Dr Reddys Laboratories Limited |
8.94 |
| Cipla Limited |
8.91 |
| Laurus Labs Limited |
6.38 |
| Lupin Limited |
6.35 |
| Torrent Pharmaceuticals Limited |
5.24 |
| Aurobindo Pharma Limited |
4.72 |
| Glenmark Pharmaceuticals Limited |
3.59 |
| Alkem Laboratories Limited |
3.52 |
| Biocon Limited |
3.22 |
| Mankind Pharma Limited |
3.11 |
| Zydus Lifesciences Limited |
3.01 |
| IPCA Laboratories Limited |
2.55 |
| Gland Pharma Limited |
2.15 |
| J B Chemicals and Pharma Ltd |
2.03 |
| Wockhardt Limited |
1.73 |
| Ajanta Pharma Limited |
1.56 |
| Abbott India Limited |
1.43 |
| Piramal Pharma Limited |
1.13 |
| Triparty Repo |
0.07 |
| Net Current Assets |
0.03 |
|
|
|
| |
|
| |
| Sector Analysis Graphical Mode |
|
| |
|
|
| |
|
 |
| |
|
|
|
